Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | TP53 | P04637 | 3/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | KCNT1 | Q5JUK3 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30890412 | 0.88 | HSD17B10 (0.36) | MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL30890406 | 0.85 | MEN1 (0.31) | MAPTTP53MEN1KMT2A | |
| SCHEMBL30890780 | 0.84 | MAOB (0.34) | MAPTTP53MEN1KMT2AAKR1B1 | |
| SCHEMBL30992283 | 0.84 | CCNB2 (0.36) | LMNAUSP2F2L3MBTL1IDO1 | |
| SCHEMBL30890474 | 0.83 | TSHR (0.32) | MEN1KMT2A | |
| SCHEMBL30890722 | 0.81 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL30890444 | 0.79 | POLB (0.36) | MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL30890404 | 0.79 | POLB (0.36) | MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL30890510 | 0.78 | OTUD7B (0.40) | MEN1KMT2AL3MBTL1 | |
| SCHEMBL30890741 | 0.77 | RECQL (0.34) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612156-A1 | ANTI-VIRAL COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024097296-A1 | ANTI-VIRAL COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |